86 related articles for article (PubMed ID: 33361638)
1. Study on the
Natarajan A; Sudha Bandla S; Damodaran M; Sundaram S; Venkatesan V
J Genet; 2020; 99():. PubMed ID: 33361638
[TBL] [Abstract][Full Text] [Related]
2. Significant Association Between Polymorphisms of Wnt Antagonist Genes and Lung Cancer.
Yilmaz M; Donmez G; Kacan T; Sari I; Akgül Babacan N; Sari M; Kilickap S
J Investig Med; 2015 Dec; 63(8):935-41. PubMed ID: 26457595
[TBL] [Abstract][Full Text] [Related]
3. SFRP4 gene expression is increased in aggressive prostate cancer.
Sandsmark E; Andersen MK; Bofin AM; Bertilsson H; Drabløs F; Bathen TF; Rye MB; Tessem MB
Sci Rep; 2017 Oct; 7(1):14276. PubMed ID: 29079735
[TBL] [Abstract][Full Text] [Related]
4. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
[TBL] [Abstract][Full Text] [Related]
6. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
7. Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro.
Horvath LG; Henshall SM; Kench JG; Saunders DN; Lee CS; Golovsky D; Brenner PC; O'Neill GF; Kooner R; Stricker PD; Grygiel JJ; Sutherland RL
Clin Cancer Res; 2004 Jan; 10(2):615-25. PubMed ID: 14760084
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms in sFRP4 are associated with bone and body composition related parameters in Danish but not in Belgian men.
Boudin E; Piters E; Nielsen TL; Andersen M; Roef G; Taes Y; Brixen K; Van Hul W
Mol Genet Metab; 2012 Jul; 106(3):366-74. PubMed ID: 22608881
[TBL] [Abstract][Full Text] [Related]
10. CD24 is a genetic modifier for risk and progression of prostate cancer.
Zhang Y; Li B; Zhang X; Sonpavde GP; Jiao K; Zhang A; Zhang G; Sun M; Chu C; Li F; Wang L; Cui R; Liu R
Mol Carcinog; 2017 Feb; 56(2):641-650. PubMed ID: 27377469
[TBL] [Abstract][Full Text] [Related]
11. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Dahiya AV; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Sep; 13(17):5056-62. PubMed ID: 17785557
[TBL] [Abstract][Full Text] [Related]
12. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.
Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
Urol Oncol; 2013 Oct; 31(7):1132-40. PubMed ID: 22317880
[TBL] [Abstract][Full Text] [Related]
13. MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer.
Xue L; Han X; Liu R; Wang Z; Li H; Chen Q; Zhang P; Wang Z; Chong T
Oncotarget; 2016 May; 7(22):31825-31. PubMed ID: 26025918
[TBL] [Abstract][Full Text] [Related]
14. Association of
Sivonova MK; Jurecekova J; Kaplan P; Hives M; Grendar M; Tomascova A; Dusenka R; Drobkova H; Evin D; Kliment J
Anticancer Res; 2020 Nov; 40(11):6257-6264. PubMed ID: 33109563
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-6 gene polymorphisms in the development of prostate cancer.
Chen CH; Gong M; Yi QT; Guo JH
Genet Mol Res; 2015 Oct; 14(4):13370-4. PubMed ID: 26535651
[TBL] [Abstract][Full Text] [Related]
16. Functional variants of the 5-methyltetrahydrofolate-homocysteine methyltransferase gene significantly increase susceptibility to prostate cancer: Results from an ethnic Han Chinese population.
Qu YY; Zhou SX; Zhang X; Zhao R; Gu CY; Chang K; Yang XQ; Gan HL; Dai B; Zhang HL; Shi GH; Zhu Y; Ye DW; Zhao JY
Sci Rep; 2016 Nov; 6():36264. PubMed ID: 27808252
[TBL] [Abstract][Full Text] [Related]
17. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
[TBL] [Abstract][Full Text] [Related]
18. P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.
Rogler A; Rogenhofer M; Borchardt A; Lunz JC; Knoell A; Hofstaedter F; Tannapfel A; Wieland W; Hartmann A; Stoehr R
Pathobiology; 2011; 78(4):193-200. PubMed ID: 21778786
[TBL] [Abstract][Full Text] [Related]
19. Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people.
Zhang Y; Li P; Xu A; Chen J; Ma C; Sakai A; Xie L; Wang L; Na Y; Kaku H; Xu P; Jin Z; Li X; Guo K; Shen H; Zheng S; Kumon H; Liu C; Huang P
Tumour Biol; 2016 May; 37(5):6653-9. PubMed ID: 26646562
[TBL] [Abstract][Full Text] [Related]
20. Role of functional polymorphisms of P53 and P73 genes with the risk of prostate cancer in a case-control study from Northern India.
Mittal RD; George GP; Mishra J; Mittal T; Kapoor R
Arch Med Res; 2011 Feb; 42(2):122-7. PubMed ID: 21565625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
